USFDA classifies inspection conducted at Cipla’s Goa facility as OAI

23 Jan 2020 Evaluate

United States Food and Drug Administration (USFDA) has classified the inspection conducted at Cipla’s Goa manufacturing facility from September 16-17, 2019 as Official Action Indicated (OAI). The Company will work closely with the agency to comprehensively address the observations received.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1491.00 11.40 (0.77%)
29-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1478.35
Dr. Reddys Lab 6009.45
Cipla 1491.00
Zydus Lifesciences 1046.55
Lupin 1601.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.